MartinAndreanskyMDPhD

Pediatric Hematology & Oncology • San Antonio, TX

Director, Pediatric Blood and Marrow Transplant Center The Children’s Hospital of San Antonio Baylor College of Medicine

Join to view full profile

Dr. Andreansky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Andreansky's full profile

Already have an account?

Office
The Children's Hospital of San Antonio
333 N Santa Rosa St
San Antonio, TX 78207
Phone+1 305-546-4868

Education & Training

St. Jude Children's Research Hospital2004
University of TennesseeFellowship, Pediatric Infectious Diseases, 2003
St. Jude Children's Research Hospital2003
University of TennesseeFellowship, Pediatric Infectious Diseases, 1999 - 2000
Penn State Milton S Hershey Medical CenterResidency, Pediatrics, 1996 - 1999
Penn State Milton S. Hershey Medical Center1999
Penn State Milton S Hershey Medical CenterInternship, Pediatrics, 1996 - 1997
Czech Academy of SciencesPhD, Biochemistry, 1986 - 1990
Comenius UniversityMD, Medicine, 1979 - 1985
Comenius UniversityClass of 1985

Certifications & Licensure

AZ State Medical License 2004 - 2026
FL State Medical License 2008 - 2026
TX State Medical License 2019 - 2026
PA State Medical License 1997 - 2006
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com

Clinical Trials

Evaluating the Safety and Effectiveness of Bone Marrow Transplants in Children With Sickle Cell Disease (BMT CTN 0601) Start of enrollment: 2008 Aug 01
Completed
Phase 2
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases Start of enrollment: 2001 Dec 01
Recruiting
Phase 1, Phase 2
Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL) Start of enrollment: 2011 Jul 18
Completed
Phase 1
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
Recruiting
Metformin in Children With Relapsed or Refractory Solid Tumors Start of enrollment: 2012 Sep 24
Completed
Phase 1
Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors Start of enrollment: 2013 Sep 03
Terminated
Phase 1
Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients With High Risk Leukemia and Myelodysplasia Start of enrollment: 2008 Aug 01
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

1 citations
Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial.
Mary Eapen, Jianqun Kou, Martin Andreansky, Monica Bhatia, Joel Brochstein
American Journal of Hematology. 2024-04-01
594 citations
Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia
Chihaya Imai, Keichiro Mihara, M. Andreansky, I. C. Nicholson, C H Pui
Leukemia. 2004-04-01
91 citations
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse
E. Coustan-Smith, Amar J. Gajjar, Nobuko Hijiya, Bassem I. Razzouk, Raul C. Ribeiro
Leukemia. 2004-03-01

Professional Memberships

American Society of Clinical Oncology - ASCO
Member